HomeNewsWorldHow deadly is the coronavirus? The true fatality rate is tricky to find, but researchers are getting closer

How deadly is the coronavirus? The true fatality rate is tricky to find, but researchers are getting closer

To calculate the infection fatality rate, researchers need to know three things: the number of infections, the number of deaths from infections and which deaths go with which infections. But finding these numbers is far harder than it might seem and these difficulties explain why there has been, and continues to be, so much uncertainty regarding this important number.

July 16, 2020 / 16:21 IST
Story continues below Advertisement

Early reports from January painted a grim picture about just how deadly the coronavirus was. Initially, the World Health Organization estimated that the percentage of infected individuals who die from COVID-19 was 3.4 percent. That statistic is called the infection fatality rate (IFR) – or colloquially, the death rate – and means that for every hundred people infected with COVID-19, on average, between three and four would die.

As time has gone on, it has become clear that the true risk of death is much lower. The Centers for Disease Control and Prevention currently has a best guess of 0.65 percent for the IFR.

Story continues below Advertisement

But current estimates fall anywhere between 0.2 percent and 1 percent, a surprisingly large range when calculating the infection fatality rate should be as simple as dividing the number of deaths by total infections.

And these estimates are changing all the time. In fact, in the time it took to write this article, the CDC changed its best estimate of the fatality rate from 0.26 percent to 0.65 percent.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show